VRTX
Vertex Pharmaceuticals Inc / MaCompany with tickers: VRTX
CIK
875320
CUSIP
92532F100
Shares Outstanding
253,805,417
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $2,986,900,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | $1,138,100,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Net Income | $1,031,400,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| EPS (Basic) | $4.06 | USD/shares | 2026-03-31 | 10-Q | 2026-05-05 |
| EPS (Diluted) | $4.02 | USD/shares | 2026-03-31 | 10-Q | 2026-05-05 |